Mahin Arastu

Mahin Arastu is an experienced professional in the biotechnology and medical writing fields, currently serving as Associate Director of Medical Writing at Corcept Therapeutics since August 2024, specializing in clinical regulatory submissions in oncology. Prior to this role, Mahin held the position of Lead Medical Writer at Acumen Medical Communications from March 2019 to July 2024, where the focus was on guiding biotechnology companies through various clinical submissions, including investigational new drug applications. Mahin co-founded Substantial Living in February 2014 and served as CEO until March 2019, successfully establishing a branding program and securing retail partnerships. Earlier career experience includes roles as Senior Associate Scientist at Biogen Idec, contributing to research on immunotherapy for neurodegenerative diseases, and as Scientist I at Alkermes, developing assays for alcohol dependence therapies. Mahin Arastu holds an MBA in Entrepreneurship from Babson F.W. Olin Graduate School of Business and a BS in Neurobiology and Behavior from the University of California, Davis.